Clinical Study

Esketamine For Treatment Resistant Depression In The Elderly

Posted Date: Jul 25, 2017

  • Investigator: Caleb Adler
  • Co-Investigator: Gayathri Pulapaka
  • Specialties: Depression, Psychiatry/Psychology
  • Type of Study: Drug

Have you been diagnosed with depression and have not responded to prior treatment with at least two antidepressants? Do you continue to have depression symptoms despite taking antidepressant medications? We are currently enrolling participants in a clinical research study to look at the effectiveness and safety of an investigational medication (given as a nasal spray) in patients with treatment-resistant depression who have not responded to prior treatment with at least two antidepressants. Compensation for your time and travel expenses may also be provided.


To Be Considered For The Study, You Must Be At Least 65 Years Old, Diagnosed With Depression And Still Be Experiencing Depression Symptoms Despite Having Taken Two Antidepressant Medications In The Past. You Must Be Comfortable With Using A Nasal Spray And Able To Provide Written Consent To Participate. The Study Doctor Will Discuss Additional Requirements For Being In The Study. If You Are Eligible For This Study And Choose To Participate, All Study Visits And Study-Related Medical Care Will Be Provided At No Cost To You.


Trd, Psychiatry, Geriatric, Depression, Treatment Resistant Depression

For More Information:

Emily Rummelhoff
(513) 558-4295

  • Search Clinical Studies

  • Research in the News

    Enhanced Recovery Program for Colorectal Surgery Patients Reduces Costs

    A standardized protocol for managing patients for the duration of colorectaloperations not only improved clinical outcomes, but also it significantlyreduced hospital costs.